City Therapeutics, Inc., a biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, announced the appointment of Andrew “Andy” Orth as chief executive...
Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, tissue-targeted medicines, announced the appointment of Glenn D. Crater, MD, as chief medical officer...
Candid Therapeutics, Inc, a clinical-stage biotechnology company focused on becoming the leader in advancing T-cell engagers for autoimmune and inflammatory diseases, announced an agreement...
BlossomHill Therapeutics, Inc., a clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, announced...
